Am Fam Physician. 2023;107(3):online
Author disclosure: No relevant financial relationships.
Details for This Review
Study Population: Adults 18 years or older with acute or chronic low back pain in one of three diagnostic groups: radicular low back pain, nonradicular low back pain, or spinal stenosis
Efficacy End Points: Improvement in pain and function, need for surgery, and quality of life
Harm End Points: Adverse events, serious adverse events, transient hyperglycemia, and withdrawal from the trial
| Benefits | Harms |
|---|---|
| 1 in 6 with radicular low back pain was helped: short-term function (two weeks to less than three months of follow-up) | No reported adverse events or serious adverse events, including transient hyperglycemia |
| 1 in 6 with radicular low back pain was helped: long-term function (12 months or greater follow-up) | |
| No other benefits in pain, function, need for surgery, or improvement in quality of life were reported for nonradicular low back pain or spinal stenosis |
Already a member/subscriber?
Log In
Subscribe
From $165- Immediate, unlimited access to all AFP content
- More than 130 CME credits/year
- AAFP app access
- Print delivery available
Issue Access
$59.95- Immediate, unlimited access to this issue's content
- CME credits
- AAFP app access
- Print delivery available
Purchase Access:
Learn More
